Articles related to AORTIC STENOSIS

In this multicenter trial of 901 patients with asymptomatic severe aortic stenosis, early TAVR intervention reduced the composite endpoint of death, stroke, or unplanned cardiovascular hospitalization by 50% compared to clinical surveillance.

Elevated plasma Lp(a) concentrations were associated with a 41% faster progression of peak aortic jet velocity and a 57% faster progression of mean transvalvular gradient in patients with aortic stenosis.

In a recent study among low-risk aortic stenosis patients, transcatheter aortic-valve implantation (TAVI) demonstrated a significant reduction in the combined endpoint of death or stroke at one year compared to surgical replacement, suggesting its potential as a safer alternative in selected patient groups.

Recent findings demonstrate that among patients with small aortic annuli undergoing TAVR, those treated with self-expanding valves experienced significantly lower rates of bioprosthetic-valve dysfunction (9.4%) compared to those with balloon-expandable valves (41.6%), emphasizing the necessity for careful valve selection in clinical practice.